Deroy & Devereaux Private Investment Counsel’s AbbVie ABBV Stock Holding History

Deroy & Devereaux Private Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-910	Closed	-$208K	–	174
2025 Q4	$208K	Sell	910 -31	-3%	-$7.06K	0.01%	171
2025 Q3	$218K	Buy	+941	New	+$192K	0.01%	166
2024 Q4	–	Sell	-1,121	Closed	-$221K	–	172
2024 Q3	$221K	Buy	+1,121	New	+$209K	0.01%	166
2024 Q2	–	Sell	-1,121	Closed	-$204K	–	168
2024 Q1	$204K	Buy	+1,121	New	+$193K	0.01%	170

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deroy & Devereaux Private Investment Counsel's ABBV Position: Q1 2026 in Review

Deroy & Devereaux Private Investment Counsel sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 910 shares — an estimated $208K sold.

Deroy & Devereaux Private Investment Counsel first reported a position in ABBV in Q1 2024 and held it in 4 quarters. The position peaked at $221K in Q3 2024. 4,090 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Deroy & Devereaux Private Investment Counsel reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
Deroy & Devereaux Private Investment Counsel sold 910 AbbVie shares in Q1 2026, an estimated $208K.
Deroy & Devereaux Private Investment Counsel first reported a position in AbbVie in Q1 2024 and held it in 4 quarters.
Deroy & Devereaux Private Investment Counsel's AbbVie position peaked at $221K in Q3 2024.
4,090 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Deroy & Devereaux Private Investment Counsel's 13F filing for Q1 2026, filed 27 Apr 2026.